Rocket Pharmaceuticals (RCKTW) Stock Price, News & Analysis

Company Overview

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing gene therapies for rare and often fatal inherited diseases. The company utilizes ex vivo lentiviral vector-based approaches to deliver functional copies of genes into patients’ hematopoietic stem cells. By targeting the underlying genetic defects, Rocket aims to provide potentially curative treatments for disorders that currently rely on lifelong supportive care or conventional interventions.

Rocket’s pipeline comprises multiple programs in various stages of development, including treatments for Fanconi anemia, primary immune deficiencies such as PNP deficiency and ADA-SCID, as well as metabolic and cardiac conditions like Danon disease and Barth syndrome. Several of these programs have advanced into clinical trials, reflecting the company’s emphasis on accelerating therapies from preclinical proof-of-concept through regulatory milestones.

Founded in 2013 and headquartered in New York, Rocket Pharmaceuticals operates primarily in the United States while collaborating with academic and clinical partners across North America and Europe. The company is led by a management team with extensive experience in gene therapy, hematology and rare disease drug development, and it continues to expand its manufacturing and clinical infrastructure to support future growth.

Key Stats

• Today's Range: $0.04 to $0.04
• 50-Day Range: $0.03 to $0.14
• 52-Week Range: $0.02 to $0.15
• Volume: N/A
• Average Volume: 23,131 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RCKTW Stock Analysis - Frequently Asked Questions

How have RCKTW shares performed this year?

Rocket Pharmaceuticals' stock was trading at $0.0343 at the start of the year. Since then, RCKTW shares have increased by 15.7% and is now trading at $0.0397.

How do I buy shares of Rocket Pharmaceuticals?

Shares of RCKTW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:RCKTW
• CIK: 1281895
• Web: www.rocketpharma.com
• Phone: 16464409100
• Fax: N/A
• Employees: 240
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A